- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05395754
Assessing the Feasibility and Preliminary Impact of a mHealth App on Reducing STI Risk in Black MSM PrEP Users
Study Overview
Status
Intervention / Treatment
Detailed Description
This unblinded, randomized study will determine the feasibility and preliminary impact of our adapted PCheck app in reducing STI infections in Black MSM PrEP users. Over 12 months, the research staff will prospectively enroll BMSM entering or already engaged in PrEP care. Participants will be randomly allocated 2:1 to the PCheck intervention versus standard of care using an automated system for randomization; the rationale for heavier allocation to the intervention is to allow for more participants to interact on the app (colleagues at the University of Virginia who have tested a similar app advised that a "critical mass" of roughly 20 participants using the community forum is needed for discussions to begin organically).15 Randomization will occur upon first meeting with the clinical research coordinator (CRC).
At enrollment, those randomized to the intervention arm will receive hands-on app onboarding training by the CRC. The training is anticipated to take 15-30 minutes and will include an overview of the app's features and how to use each, coaching about using the daily check-in feature to record mood, stress levels, and recent sexual activity and condom use, guidance on creating an anonymous introductory post to the community board, and practice using each of the PCheck features. Participants allocated to the intervention arm will receive the intervention (use of the PCheck app) for 12 months of follow-up. Participants will be encouraged to use the app as much as they wish throughout the study and will be informed that there will be no set expectation for how frequently they must use the app, although they will be encouraged to use it regularly to "thoroughly test it". The app will send notification reminders to "check in" (in other words, use the daily check-in feature to track their mood, stress, and behaviors related to STI-prevention over time). The notification settings can be adjusted in phone settings by the participant.
For participants receiving the app intervention, study staff will also schedule a follow-up call within two weeks after enrollment to encourage engagement, to talk through any difficulties that arise with using the app and to troubleshoot. During the 12 months of enrollment, study staff will contact participants at the 1, 2, 4, and 12 week marks after they stop showing usage on the app to encourage re-engagement and address any technical or other barriers.
To encourage engagement with the app, the research team will post short quizzes on the app's landing page and reminders about them on the community message board. The study will pilot once-a-day trivia questions, and adjust the frequency of trivia postings pending on participant engagement and/or feedback. Each set of trivia questions will take a couple minutes to complete and will ask 1-2 questions such as general knowledge about STIs, sexual health and wellness, and/or general New Orleans-specific or LGBTQI+ history. All participants who complete 100% of the quizzes for the week will be entered into a raffle for an additional $10 loaded onto their Clincard.
For app users, data will be extracted directly from the PCheck app, including app usage and data from the app's check-in, PrEP adherence, and STI prevention features. App data will be de-identified except for anonymous username and study ID number, which can be linked to identifying information in order to contact individuals not showing usage on the app, as described above.
For all participants, STI (syphilis, gonorrhea, chlamydia, HIV) screening will occur every three months and HCV screening every 6-12 months over 12 months of follow-up as part of routine care. Every three months, all participants will also complete self-administered questionnaires with demographic, social, and behavioral assessments. Participants allocated to the standard of care control group will be informed that their participation entails attending routine PrEP appointments, including STI screening, and completing the quarterly surveys. For those in the intervention arm, participants will also answer questions aimed at assessing app acceptability, feasibility, and usability.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Meredith Clement, MD
- Phone Number: 252-902-4961
- Email: mclem5@lsuhsc.edu
Study Contact Backup
- Name: Clare Kelsey, MS
- Phone Number: 225-454-5941
- Email: ckelse@lsuhsc.edu
Study Locations
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70119
- Recruiting
- CrescentCare PrEP Clinic
-
Contact:
- Meredith Clement, MD
- Phone Number: 252-902-4961
- Email: mclem5@lsuhsc.edu
-
Principal Investigator:
- Meredith Clement, MD
-
New Orleans, Louisiana, United States, 70119
- Recruiting
- LSU-CrescentCare Sexual Health Center
-
Contact:
- Meredith Clement, MD
- Phone Number: 252-902-4961
- Email: mclem5@lsuhsc.edu
-
Principal Investigator:
- Meredith Clement, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Cisgender man who has sex with cisgender men (MSM) including gay, bisexual, or other MSM
- Age 18-35 years
- Black race or multi-racial including Black race
- Prescribed, administered or otherwise taking PrEP via routine care or PrEP clinical trial
- Smartphone possession
Exclusion criteria:
- Unable to read and write
- Not fluent in English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: PCheck
Participants allocated to the intervention arm will receive the intervention (use of the PCheck app) for 12 months of follow-up.
Participants will be encouraged to use the app as much as they wish throughout the study and will be informed that there will be no set expectation for how frequently they must use the app, although they will be encouraged to use it regularly to "thoroughly test it".
The app will send notification reminders to "check in" (in other words, use the daily check-in feature to track their mood, stress, and behaviors related to STI-prevention over time).
The notification settings can be adjusted in phone settings by the participant.
To encourage peer support and a sense of community, users can interact with community members anonymously through a message board, monitored by research staff.
Participants in the intervention will continue routine PrEP care and STI testing through the clinic.
|
Use of the PCheck app, an app encouraging STI prevention behaviors.
|
NO_INTERVENTION: Routine Care
Participants in the routine care arm will continue routine PrEP care and STI testing through the clinic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
STI incidence
Time Frame: 12 months
|
New diagnosis of syphilis, gonorrhea, chlamydia, or hepatitis C per 100 person-years.
Number of new HIV diagnoses.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social Support
Time Frame: 12 months
|
Scaled score on the Social Provisions Scale-10.
The minimum score is 10 and maximum score is 40.
Higher scores indicate a higher degree of social support.
|
12 months
|
Social Isolation
Time Frame: 12 months
|
Scaled score on the Patient-Reported Outcomes Measurement Information System (PROMIS) Social Isolation Subscale.
Higher scores indicate a higher degree of social isolation or disconnection from others.
The minimum score is 4 and maximum score is 20.
|
12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Meredith Clement, MD, LSUHSC
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2268
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sexually Transmitted Diseases
-
Columbia UniversityNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingSTI | Sexually Transmitted Disease (STD) | Sexually Transmitted Infection (STI)United States
-
National Institute of Allergy and Infectious Diseases...Terminated
-
Boston Medical CenterCompletedSexually Transmitted InfectionUnited States
-
University of ChicagoCompletedSexually Transmitted InfectionUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedSexually Transmitted InfectionFrance
-
University of California, San FranciscoNational Institute of Mental Health (NIMH); MRC/UVRI and LSHTM Uganda Research... and other collaboratorsCompletedSexually Transmitted InfectionUganda
-
University of Illinois at ChicagoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedHiv | Sexually Transmitted InfectionSouth Africa
-
Boston Medical CenterCompletedSexually Transmitted InfectionUnited States
-
Chinese University of Hong KongRecruitingGonorrhea | Sexually Transmitted InfectionHong Kong
-
Sagami Rubber Industries Co., Ltd.Essential Access HealthCompletedContraception | Prevention of Sexually Transmitted InfectionsUnited States
Clinical Trials on App Intervention
-
Chang Gung UniversityChang Gung Memorial HospitalRecruiting
-
Big Health Inc.National Institute of Mental Health (NIMH); Duke UniversityActive, not recruiting
-
Kent State UniversitySumma Health SystemUnknown
-
The University of Texas Health Science Center at...National Cancer Institute (NCI); Wake Forest University Health Sciences; Arizona... and other collaboratorsRecruitingDepression | Inflammation | Cancer | Fatigue | Anxiety | Sleep DisturbanceUnited States
-
The University of Hong KongCompleted
-
Ksana HealthNovo Nordisk A/SCompletedObesity | Overweight | Mental Health DisorderUnited States
-
Rubén Martín PayoRecruiting
-
China National Center for Cardiovascular DiseasesUnknownMedication Adherence | Mobile Applications | Coronary Artery Bypass GraftingChina
-
Fundació d'investigació Sanitària de les Illes...Hospital Son Espases; Fundació Institut de Recerca de l'Hospital de la Santa... and other collaboratorsCompletedDepression | Anxiety Disorders | Burnout | Mental Health Disorder | Posttraumatic Stress DisorderSpain
-
University of California, DavisCompletedBehavior, HealthUnited States